# Media Overview

Boehringer Ingelheim’s Hub for providing you with the latest Press Releases and further Press Material for Download.

## Press Releases

### [Emirates Drug Establishment Approves a new Lung Disease Treatment from Boehringer Ingelheim](/content/mea/human-health/lung-diseases/emirates-drug-establishment-approves-new-lung-disease-treatment-boehringer-ingelheim "Emirates Drug Establishment Approves a new Lung Disease Treatment from Boehringer Ingelheim"/index.html)  
  
June 26, 2026

### [Football’s Yellow Card Becomes a Call for Action on Cardiovascular, Renal, and Metabolic Health at Boehringer Ingelheim’s CRM United Event](/content/mea/human-health/metabolic-diseases/footballs-yellow-card-becomes-call-action-cardiovascular-renal-and-metabolic-health-boehringer "Football’s Yellow Card Becomes a Call for Action on Cardiovascular, Renal, and Metabolic Health at Boehringer Ingelheim’s CRM United Event"/index.html)  
  
November 24, 2025

### [FIBRONEER™ global phase III trials](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/fibroneer-global-phase-iii-trials "FIBRONEER™ global phase III trials"/index.html)  
  
June 04, 2025

## Media Contacts

### Feda Kassem
  
Manager, Corporate Communications, IMETA, Corporate Affairs

### Atalia Faria
  
Specialist, Communications IMETA, Corporate Affairs

## Current Events

### Please check back later!

There are no upcoming events in the near future.

## Past Events

### [Annual Results Press Conference 2022](/content/mea/annual-results-press-conference-2022 "Annual Results Press Conference 2022"/index.html)  
  
Event

### Annual Results Press Conference 2022
- April 5, 2022  
- 10:30 am  
- Ingelheim, Germany

### Press Material

Access our media pool and Animal Health press kit.  
[Read more](/content/mea/press-material/index.html)

### References